abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

7 Aug 2009

Author:
Kaiser Daily Global Health Policy Report [USA]

Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug

Former President Bill Clinton on Thursday announced deals with drugmakers Matrix Laboratories [part of Mylan] and Pfizer to lower the cost of medications to treat patients with drug-resistant HIV in the developing world…the 2010 cost for the four drugs "is 28 percent lower than the current lowest-priced alternative"…Matrix will also "make ritonavir available in a heat-stable version more suitable for tropical climates"…